A round-up of notable broker activity this morning from Europe's top-ranked* analysts:
** Goldman Sachs downgrades Germany's Deutsche Bank DBKGn.DE to "neutral" from "buy" and Commerzbank to "sell" from "neutral" based on their high valuation and significant year-to-date outperformance
INITIATIONS AND REINSTATEMENTS
** Citigroup resumes coverage of Italy's second-largest bank UniCredit CRDI.MI with a "buy" rating on higher earnings forecasts and potential M&A opportunities
** J.P. Morgan initiates coverage of bioMérieux BIOX.PA with a "neutral" rating, saying the company's strengths and growth prospects are already priced in the stock
** J.P. Morgan initiates coverage on Italian medical diagnostics group DiaSorin DIAS.MI at "underweight" with a 75.40 euros ($88.27) price target, citing structural challenges and limited scope for margin progression
(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)
(Reporting by Alessandro Parodi and Olivier Cherfan)
((Alessandro.Parodi@thomsonreuters.com;))